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Atherosclerosis is a complex multifactorial disease, and individual susceptibility to plaque development is influ-
enced by many genetic factors. We previously showed that 
plaque size in mice is dependent on the strain and vascular 
location in the early stage of atherosclerosis.1–4 At the aortic 
root, apolipoprotein E–deficient (Apoe−/−) mice on a DBA/2J 
background (DBA/2J-Apoe−/−) develop larger plaques than 
those on a C57BL/6J background (C57BL/6J-Apoe−/−), 
whereas Apoe−/− mice on a 129S6 background (129S6-Apoe−/−) 
are resistant to plaque development compared with DBA/2J-
Apoe−/− or C57BL/6J-Apoe−/− mice. In the aortic arch area, 
however, 129S6-Apoe−/− and DBA/2J-Apoe−/− mice show 
larger lesion size than C57BL/6J-Apoe−/− mice. These obser-
vations clearly indicate that the location specificity of plaque 
development is genetically controlled.
Our QTL analysis using an intercross between DBA/2J-
Apoe−/− and 129S6-Apoe−/− revealed Aath4, an atherosclerosis 
QTL for the aortic arch area on the distal part of chromosome 
2 (Peak: 137 Mb, confidence interval: 123−148 Mb).4 The 
DBA/2J allele of Aath4 confers susceptibility to atheroscle-
rosis, whereas the 129S6 allele confers resistance. Aath4 was 
not detected in a C57BL/6J-Apoe−/− × 129S6-Apoe−/− cross,2 
indicating that Aath4 sequences unique to DBA/2J are respon-
sible for the different phenotypes. Many candidate genes are 
present in the chromosomal region in which Aath4 resides, 
including several phagocytosis-related genes.
One of the candidates is c-mer proto-oncogene tyrosine 
kinase (Mertk) located at 128.5 Mb, which encodes a member 
of the TAM (Tyro3, Axl, and Mer) receptor tyrosine kinase 
family. MERTK is primarily expressed in monocytes as well 
as in epithelial and reproductive tissues,5 and it is involved 
in phagocytosis of apoptotic cells.6,7 It has 2 immunoglob-
ulin-like domains and 2 fibronectin type III domains in the 
extracellular region, and binds to apoptotic cells via bridg-
ing molecules such as GAS6 and protein S.5,8,9 The binding 
promotes phosphorylation of the tyrosine kinase domain 
located within the intracellular region of MERTK; this phos-
phorylation leads to activation of downstream signaling 
and induces structural changes in cytoskeletons, enabling 
the cell to engulf its target cells.10 Macrophages from mice 
with an inactivated Mertk kinase domain (Mertk−/−) are defi-
cient in the clearance of apoptotic cells (efferocytosis).6 The 
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Mertk−/− mice are viable, but show retinal degeneration, 
because of the failure of the retinal pigment epithelium to 
engulf the outer segments of photoreceptors.7,11 MERTK also 
plays a pivotal role in atherosclerotic plaque development via 
its effects on efferocytosis: Mertk deficiency in Apoe−/− mice 
promotes accumulation of apoptotic cells and expansion of 
necrotic cores within plaques12; and low-density lipoprotein 
receptor-deficient (Ldlr−/−) mice with Mertk−/− bone mar-
row show accumulation of apoptotic cells and accelerated 
atherosclerosis.13
In this study, we have generated and studied a mouse line, 
Aath4aDBA/DBA, in which a 5′ region of the Aath4 from DBA/2J 
has been transferred onto a 129S6-Apoe−/− background. We 
show that these mice have elevated plaque susceptibility and 
reduced efferocytosis by macrophages. We also demonstrate 
that decreased transcription of Mertk, not DBA-unique amino 
acid alterations in MERTK, determines the limited efferocyto-
sis that occurs in Aath4aDBA/DBA mice.
Materials and Methods
Materials and Methods are available in the online-only Data 
Supplement.
Results
Generation of Aath4aDBA/DBA Mice
Aath4aDBA/DBA congenic mice were constructed by backcross-
ing DBA/2J-Apoe−/− mice to the 129S6-Apoe−/− strain for more 
than 7 generations. The backcrossed genomic segments in chro-
mosome 2 (117–137 Mb) are shown in Figure 1A. The DBA 
allele of SNP (single nucleotide polymorphism) rs27446327 
was used as a marker for Chr 2: 128 Mb. Heterozygous mice 
were mated to generate homozygotes. SNPs rs30884601, 
rs36935260, rs48427643, and rs30243498 were also typed at 
early generations to ensure that DBA alleles at other athero-
sclerosis QTLs (Chr 1: 155 Mb, Chr 1: 165 Mb, Chr 2: 143 
Mb, and Chr 10: 86 Mb) were eliminated.
Aath4aDBA/DBA Male Mice Develop Larger 
Plaques With Increased Calcium Deposits
As summarized in Table 1, Aath4a129/129 control mice and 
Aath4aDBA/DBA mice showed no significant differences in body 
weight. In males, plasma cholesterol levels were almost the 
same between controls and Aath4aDBA/DBA, whereas triglycer-
ides were significantly higher in Aath4aDBA/DBA (P=0.002). In 
female Aath4aDBA/DBA mice, plasma total cholesterol was lower 
(P=0.010) and HDL-cholesterol was higher (P=0.016) com-
pared with Aath4a129/129 controls, but triglycerides were not 
significantly different.
At 5 months of age, Aath4aDBA/DBA male mice developed 
≈50% larger plaques at the inner curve of the aortic arch com-
pared with control mice (P<0.05; Figure 1B, left). Plaque size at 
Nonstandard Abbreviations and Acronyms
Aath4 arch atherosclerosis 4
LPMs large peritoneal macrophages
SPMs small peritoneal macrophages
Figure 1. Aath4aDBA/DBA males develop larger atherosclerotic plaques. A, Haplotype maps of Chr 2 taken from the Mouse Phylogeny 
Viewer (http://msub.csbio.unc.edu/#viewer). 129S6 sequence is colored in green (top), genomic regions where DBA/2J share the same 
sequences as 129S6 are shown in green, and DBA/2J-specific sequences are highlighted with purple (middle), and C57BL/6J unique 
regions are colored in peach (bottom). The backcrossed region in the congenic strain Aath4aDBA/DBA (red bar), position of Aath4 (black bar), 
and the location of some of the candidate genes (arrows) are indicated. B, Comparison of plaque size at the aortic arch (left) and root 
(right) between the control Aath4a129/129 (filled bars) and Aath4aDBA/DBA (open bars) mice at 5 mo old. Plaque size is indicated in square root 
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the aortic root was also significantly larger in Aath4aDBA/DBA males 
(P<0.01; Figure 1B, right). In contrast, females did not show sig-
nificant differences in the size of either aortic arch or aortic root 
plaques. Male Aath4aDBA/DBA mice also developed significantly 
larger brachiocephalic artery lesions compared with the control 
(P<0.05), but did not differ in the left common carotid and left 
subclavian arteries. In females, no significant difference was 
observed in any of these branches between Aath4aDBA/DBA mice 
and controls (Figure I in the online-only Data Supplement).
The plaques developing in the aortic roots of Aath4aDBA/DBA 
and control mice ranged from a monolayer of foam cells to 
complex lesions with inflammation and necrotic cores (Figure 
2A; Figure II in the online-only Data Supplement). When 
plaques of similar size and locations were examined histo-
logically, the early raised lesions of Aath4aDBA/DBA contained 
more scattered basophilic calcium deposits (Figure 2A and 
2B) than the Aath4a129/129 control plaques. Multiple calcium 
deposits were detectable, often associated with the acellular 
necrotic cores, in the raised plaques in 28 of 36 Aath4aDBA/DBA 
mice compared with 6 of 28 Aath4a129/129 control mice. In 
more mature plaques, calcium deposits were detected equally 
in both Aath4aDBA/DBA mice and Aath4a129/129 controls, and they 
were located deeper in the plaques, near the internal lamina 
(Figure IIE and IIF in the online-only Data Supplement, 
arrowheads). Enhanced cell death or reduced clearance of 
dead cells could be the source of these calcium deposits. 
Although very few, TUNEL (terminal deoxynucleotidyl trans-
ferase dUTP nick-end labeling)-positive nuclei were detected 
within the plaques of both Aath4a129/129 and Aath4aDBA/DBA mice 
(Figure III in the online-only Data Supplement).
Because average lesions were significantly larger in size 
and more advanced in Aath4aDBA/DBA mice than in Aath4a129/129, 
we selected 7 raised lesions with similar size from Aath4a129/129 
and Aath4aDBA/DBA mice to compare the components of the early 
to intermediate stage plaques. Necrotic area was ≈5× larger in 
Aath4aDBA/DBA than in control mice (Figure 2C). Fibrous cap 
thickness was variable, and the difference was not statistically 
significant between the 2 groups (Figure 2D). However, col-
lagen content in these lesions was less in the Aath4aDBA/DBA 
mice, suggesting that resolution of inflammation associated 
with the plaque development is likely delayed in Aath4aDBA/DBA 
(Figure 2E). General inflammation in these mice was low, 
judged by the low concentration of transforming growth 
factor-β1 and undetectable interleukin-10 in plasma. No sig-
nificant differences in mRNA levels of interleukin-1β and 
transforming growth factor-β1 in the aorta were observed 
between control Aath4a129/129 and Aath4aDBA/DBA mice or in 
plasma transforming growth factor-β1 levels (Figure IVA and 
IVB in the online-only Data Supplement), probably because 
these mice were fed with normal chow.
Together these results indicate that the DBA/2J allele of 
the 5′ region of Aath4 enhances atherosclerosis in both the 
aortic arch and the root. Increased cell death in the early 
stages of plaque development may be associated with this 
enhancement.
Reduced Mertk Expression in 
Aath4aDBA/DBA Macrophages
The Aath4a QTL includes Mertk, which is important for 
efferocytosis, the phagocytotic removal of apoptotic cells.4 
MERTK is localized on cell surface where it is proteolytically 
cleaved by ADAM metallopeptidase domain 17 (ADAM17) 
to produce soluble MER (sMER). sMER attenuates MERTK-
triggered intracellular signaling by blocking bridging mol-
ecules.14 In thioglycollate-elicited peritoneal macrophages 
isolated from Aath4aDBA/DBA, Mertk mRNA levels were less 
than 50% of that in Aath4a129/129 control macrophages (Figure 
3A). In parallel with the mRNA expression, the amount of 
MERTK protein in cultured macrophages was also reduced in 
Aath4aDBA/DBA (Figure 3B), as well as cell-surface expression 
of MERTK (Figure 3C).
sMER in the conditioned medium of Aath4aDBA/DBA mac-
rophage and plasma sMER in Aath4aDBA/DBA mice were also 
reduced compared with those in controls, consistent with the 
reduction of protein amounts in macrophages (Figure 3B and 
3D). MERTK protein was abundantly present within the ath-
erosclerotic plaques of the Aath4a129/129 control mice, border-
ing the macrophage marker CD68-positive area, whereas the 
amount was significantly decreased in Aath4aDBA/DBA plaques 
(Figure V in the online-only Data Supplement).
Reduced Phagocytosis in Aath4aDBA/DBA Macrophages
MERTK is important for the normal execution of efferocytosis 
during atherosclerotic plaque development.12,13 We, therefore, 
examined phagocytosis of apoptotic Jurkat T cells by perito-
neal macrophages of Aath4aDBA/DBA mice and found that the 
uptake of apoptotic cells was reduced to ≈40% of Aath4a129/129 
controls (Figures 4A through 4C; Figure VI in the online-only 
Data Supplement).
Ghosn et al15 have reported that there are two types of peri-
toneal macrophages: large peritoneal macrophages (LPMs) 
and small peritoneal macrophages (SPMs).16 LPMs predom-
inate in the steady state peritoneal cavity but are decreased 
by inflammatory stimuli such as lipopolysaccharide and 
Table. Body Weights and Plasma Lipids in the Control and 
Aath4aDBA/DBA Mice
 Aath4a129/129 (n) Aath4aDBA/DBA (n)
Body weight, g
  Male 28.59±0.37 (33) 28.08±0.42 (23)
  Female 21.30±0.38 (27) 21.37±0.37 (20)
T-Chol, mg/dL
  Male 680.9±23.0 (37) 738.2±29.2 (23)
  Female 572.3±27.5 (26) 482.2±31.3* (20)
HDL-C, mg/dL
  Male 79.4±5.0 (33) 77.1±9.5 (9)
  Female 45.1±3.7 (26) 60.2±4.2* (20)
TG, mg/dL
  Male 79±9 (33) 125±8† (23)
  Female 48±4 (25) 58±5 (19)
Data are shown as the mean±SE. HDL-C indicates high-density lipoprotein 






 http://ahajournals.org by on A
ugust 12, 2019
Kayashima et al  Atherosclerosis and the DBA/2J Allele of Mertk  e85
Figure 2. Aath4aDBA/DBA mice develop plaques with increased calcium deposits, larger necrotic core, and less collagen content. A, Repre-
sentative early but raised plaques at the aortic root of control Aath4a129/129 (129/129) and Aath4aDBA/DBA (DBA/DBA) mice at 5 mo of age. The 
plaques with similar sizes stained with SudanIVB and hematoxylin are shown. Aath4aDBA/DBA mouse (right) contains extensive calcium depos-
its (arrowheads). B, Calcium deposits detected by von Kossa stain. Numerous deposits were observed in the early plaques of Aath4aDBA/DBA 
mice (right), whereas rarely seen in those of control Aath4a129/129 mice (left). Bar=100 μm. C, Necrotic core size in the plaques of Aath4a129/129 
(129/129) and Aath4aDBA/DBA (DBA/DBA) mice at 5 mo old. Advanced lesions that are similar in total size were selected and necrotic area was 
measured in the selected lesions (n=7). D, Fibrous cap thickness of advanced plaques. In the 7 advanced lesions selected in C, fibrous cap 
thickness was measured at 3 sites per lesion and averaged. E, Collagen content in the advanced lesions detected by trichrome staining. The 
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thioglycollate, which induce infiltration of SPMs into the peri-
toneal cavity from myeloid progenitor cells in the bone mar-
row. We found that 3 days after stimulation by thioglycollate, 
the percentage of LPM was significantly smaller in Aath4aDBA/
DBA than in control mice (0.8% versus 3.0% in Aath4aDBA/
DBA and control mice, respectively; P<0.001; Figure 5A and 
5B). Both SPMs and LPMs express MERTK, although in 
Aath4aDBA/DBA macrophages, MERTK was markedly reduced in 
both SPMs and LPMs (Figure 5C). Consistent with a previous 
report, phagocytosis was higher in LPMs than in SPMs,17 but 
importantly, both LPMs and SPMs showed similarly reduced 
phagocytosis in Aath4aDBA/DBA macrophages (Figure 5D).
MERTK Amino Acid Differences 
Do Not Affect Efferocytosis
There are 9 amino acid substitutions between 129S6 and 
DBA/2J MERTK, 3 of which (W25G, T80E, and S479R) are 
predicted to potentially alter protein function (Figure 6A).4 
The S479R substitution located adjacent to the ADAM17 
cleavage site does not seem to have a significant effect on the 
shedding of MERTK because the proportion of sMER:MER 
was not altered between control and Aath4aDBA/DBA macro-
phages (Figure 3B). Likewise, when plasmids carrying Mertk 
cDNA of 129S6 or DBA/2J were transfected into HEK293T 
(human embryonic kidney 293T) cells, MERTK protein 
expression was similar, and comparable amounts of sMER 
were detected in the respective culture medium (Figure 6B). 
These results suggest that W25G, which is located close to the 
cleavage site of the secretion signal peptide, does not affect 
the protein maturation process.
We next examined the ability of the HEK293T cells 
expressing MERTK to phagocytose apoptotic Jurkat T cells. 
Overexpression of MERTK increased phagocytosis of apop-
totic Jurkat T cells compared with the empty vector-trans-
fected control cells, but no significant difference was observed 
between the 129S6 and the DBA/2J (empty vectors: 0.8±0.5%, 
129S6-MERTK: 28.4±1.5%, and DBA/2J-MERTK: 
29.5±1.5%; Figure 6C). Addition of protein S, which bridges 
apoptotic cells and MERTK, stimulated phagocytosis in all of 
them, but a genetic effect was not observed (empty vectors: 
4.1±1.6%, 129S6-MERTK: 45.3±1.5%, and DBA/2J-MERTK: 
48.7±2.7%; Figure 6C). Thus, the T80E substitution in the first 
immunoglobulin-like domain, which contains a ligand binding 
site, does not affect the binding to bridging protein S. These 
results indicate that the DBA/2J-specific amino acid substitu-
tions in MERTK do not affect phagocytotic function.
Differences in Mertk Expression 
Levels Modulate Efferocytosis
Previous works have shown that mice lacking Mertk and 
Apoe (Mertk−/−Apoe−/−) have increased accumulation of apop-
totic cells and expanded necrotic cores in their plaques when 
compared with Mertk+/+Apoe−/− mice,12 and that peritoneal 
macrophages from Mertk-deficient mice (Mertk−/−) phagocy-
tose apoptotic cells at a much reduced level (<20% compared 
with Mertk+/+ macrophages).6 This raises the question whether 
differences in the level of expression of MERTK affect effe-
rocytosis in a graded manner. To test this, we examined phago-
cytosis of apoptotic Jurkat T cells by peritoneal macrophages 
isolated from wild-type (Mertk+/+) and Mertk heterozygous 
Figure 3. Expression of MERTK is decreased in Aath4aDBA/DBA. A, Mertk mRNA expression in thioglycollate-elicited peritoneal macrophages 
from control Aath4a129/129 (129/129) and Aath4aDBA/DBA (DBA/DBA) mice measured by quantitative RT-PCR (n=4). B, MERTK protein expres-
sion in cultured peritoneal macrophages and soluble form of MERTK (sMER) in their medium detected by western blotting (left). Signal 
intensity ratios of sMER in the conditioned medium and cell-associated MERTK (right). C, Cell-surface expression of MERTK in perito-
neal macrophages analyzed by flow cytometry. An overlay of representative histograms showing MERTK-positive cells is displayed (left). 
Median fluorescence intensity (MFI) of MERTK in CD11b-positive macrophages (right). D, sMER in the plasma detected by Western blot-
ting. Equal amounts of plasma (2.5 μL per lane) were loaded in each lane. Data are shown as the mean±SE. Numbers in the bar diagrams 
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(Mertk+/−) mice. We found that Mertk heterozygous macro-
phages, which are supposed to express 50% of MERTK, show 
≈70% phagocytosis compared with wild-type macrophages 
(P=0.002; Figure 6D), indicating that the amount of MERTK 
modulates efficiency of phagocytosis.
In agreement, when the amount of Mertk-plasmid trans-
fected to HEK293 cells was gradually decreased, cell sur-
face 129-MERTK and DBA-MERTK and phagocytosis were 
equally reduced (Figure 6E). We conclude that the amount of 
MERTK determines the efficiency of phagocytosis in a dose-
dependent, not an all-or-none manner, and that decreased 
Mertk expression in Aath4aDBA/DBA macrophages is the cause 
of the reduced phagocytosis.
Transcription Activity of the Proximal 
Promoter Region of Mertk
There are a large number of nucleotide polymorphisms 
throughout the Mertk gene, which could affect steady state 
levels of mRNA by affecting its stability. Accordingly, to clar-
ify the cause of reduced Mertk mRNA in Aath4aDBA/DBA mac-
rophages, we asked whether the degradation of Mertk mRNA 
is enhanced in Aath4aDBA/DBA macrophages. We found that the 
estimated half-life of Mertk mRNA was 5.6 hours in the control 
Aath4a129/129 macrophages and 5.7 hours in the Aath4aDBA/DBA 
macrophages, suggesting that the lower amount of Mertk 
mRNA in Aath4aDBA/DBA macrophages is likely caused 
by reduced Mertk transcription, rather than by faster 
Figure 4. Efferocytosis is reduced in Aath4aDBA/DBA macrophages. 
A, Phagocytosis of apoptotic Jurkat T cells by peritoneal mac-
rophages. Apoptotic Jurkat T cells labeled with pHrodo Red 
were added to macrophages isolated from control Aath4a129/129 
(129/129) and Aath4aDBA/DBA (DBA/DBA) mice and incubated for 1 
h at 37°C. Apoptosis of Jurkat T cells was confirmed as shown in 
Figure IIA in the online-only Data Supplement. B, Representative 
flow cytometry panels showing phagocytosis of apoptotic Jur-
kat T cells by peritoneal macrophages from control Aath4a129/129 
(129/129) and Aath4aDBA/DBA (DBA/DBA) mice. Detailed gating 
strategy is shown in Figure IIB in the online-only Data Supple-
ment. Apoptotic Jurkat T cells and macrophages were labeled 
with pHrodo Red and anti–CD11b-FITC, respectively. Gates 
indicate pHrodo Red–positive macrophages phagocytosing 
apoptotic cells. C, An overlay of representative histograms show-
ing pHrodo Red–positive phagocytosing cells in the CD11b-
positive macrophages (left). Phagocytosis assessed by the 
median fluorescent intensity (MFI) of pHrodo Red (right, n=4). 
Data are shown as the mean±SE. FITC indicates fluorescein 
isothiocyanate.
Figure 5. Small peritoneal macrophages (SPMs) and large perito-
neal macrophages (LPMs) in Aath4aDBA/DBA mice. A, Representa-
tive flow cytometry panels showing SPM and LPM populations in 
control Aath4a129/129 (left) and Aath4aDBA/DBA (right) mice. SPMs are 
defined as a F4/80lowCD11blow and LPMs as a F4/80highCD11bhigh 
population. B, Percentage of SPMs and LPMs in control 
Aath4a129/129 (129/129) and Aath4aDBA/DBA (DBA/DBA) macro-
phages. Data are representative of 5 independent experiments 
each using 4 to 5 mice of each genotype. C, Cell-surface expres-
sion of MERTK on SPMs and LPMs measured by flow cytometry 
(n=3). D, Phagocytosis in SPMs and LPMs assessed by MFI of 
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degradation of Mertk mRNA (Figure VII in the online-only 
Data Supplement).
We next searched for DBA/2J-specific differences in 
the promoter region of the Mertk gene that could affect the 
efficiency of transcription. Within the 1.1 kb immediately 
upstream of the Mertk transcription start site, there are 10 
SNPs and 1 deletion that are unique to DBA compared with 
B6 and 129 sequences (Figure VIIIA in the online-only Data 
Supplement). The Mertk gene has a CpG island promoter and 
does not contain a typical TATA box or CAAT box.
To test whether the sequence differences in the proxi-
mal promoter region of Mertk affect the transcription level, 
we compared promoter activity of 129S6 and DBA/2J by 
a luciferase reporter assay. Mertk promoters of both 129S6 
and DBA/2J enhanced luciferase expression in HEK293T 
cells ≈5× compared with empty vector, but the transcription 
activities of the Mertk promoter from 129S6 and DBA/2J 
were not significantly different (Figure VIIIB in the online-
only Data Supplement). Furthermore, addition of factors that 
are thought to regulate Mertk expression18 including granu-
locyte-macrophage colony-stimulating factor, macrophage 
colony-stimulating factor, and interleukin-4 did not signifi-
cantly change the promoter activities (Figure VIIIC in the 
online-only Data Supplement). Our experiments suggest that 
the genomic variants affecting the expression of Mertk must 
reside outside of this proximal 1.1 kb promoter region.
Indeed, when we searched for eQTLs associated with the 
expression levels of Mertk from Hybrid Mouse Diversity Panel 
by UCLA (https://systems.genetics.ucla.edu/data/hmdp),19 
more than 15 SNPs within the Aath4a interval were signifi-
cantly associated with Mertk expression levels (Table I in the 
online-only Data Supplement). The SNPs that are shared by 
Figure 6. Phagocytosis of apoptotic cells is not affected by amino acid substitutions in DBA MERTK, but is modulated by the amount of 
MERTK. A, Schematic structure of mouse MERTK indicating the 9 amino acids, which differ between 129S6 and DBA/2J proteins. Sub-
stitutions are shown as 129S6-amino acid position-DBA/2J. B, Expression of MERTK in HEK293T (human embryonic kidney 293T) cells 
and sMER in the conditioned medium detected by Western blotting. C, Phagocytosis of apoptotic Jurkat T cells by Mertk-transfected 
HEK293T cells with or without 25 nmol/L of protein S (n=3). D, Phagocytosis of apoptotic Jurkat T cells by peritoneal macrophages iso-
lated from Mertk+/+ and Mertk+/− mice (n=4). Data are shown as the mean±SE. E, Correlation between the MERTK levels and phagocytosis 
in HEK293T cells transfected with varying amounts of Mertk cDNA. 129 indicates 129S6-Mertk transfected cells; DBA, DBA/2J-Mertk 
transfected cells; EV, empty vector control; FN-III, fibronectin type-III domains; Ig-like, immunoglobulin-like domains; N.S., not significant; 
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129 and B6 but unique in DBA, and located between 63 kb 
and 2.6 Mb upstream of the Mertk gene, seem to regulate 
its expression in the liver and adipose tissue, whereas SNPs 
located between 2.3 and 2.5 Mb downstream were broadly 
associated with the expression levels in macrophages (Table 
I in the online-only Data Supplement). Two SNPs at −325 
and −202 kb upstream also showed strong association with 
the Mertk expression in macrophages, but 129 and DBA share 
the same variants at these positions. Together, it is likely that 
distant genetic variants affect the expression of Mertk.
Discussion
Each QTL identified in the crosses of inbred mice generally 
spans a large genomic distance, sometimes almost an entire 
chromosome. In complex phenotypes such as atherosclerosis, 
where a large number of genes are involved, transferring a tar-
get region onto an inbred background and creating congenic 
line is a powerful step toward identifying causative genes. Here 
we have analyzed the effect of the atherosclerosis QTL Aath4 
by establishing a congenic line (Aath4aDBA/DBA), where the 5′ 
region of DBA Aath4 was backcrossed onto a 129S6-Apoe−/− 
background. As expected, the resulting Aath4aDBA/DBA males had 
significantly larger plaques, and macrophages isolated from 
these mice exhibited reduced efferocytosis as a consequence of 
allele-specific decrease in MERTK expression. Together, our 
results provide strong evidence that the increased susceptibil-
ity to atherosclerosis determined by the DBA allele of Aath4 
is, at least in part, due to decreased MERTK expression.
MERTK is known to play a significant role in efferocytosis 
and the resolution of inflammation during atherosclerosis.12,13 In 
this report, we have demonstrated that 9 nonsynonymous SNPs 
in Mertk, which are uniquely different in DBA/2J compared with 
C57BL/6J and 129S6, are not responsible for the reduced effero-
cytosis observed in peritoneal macrophages from Aath4aDBA/DBA. 
Notably, our experiments demonstrated that the level of MERTK 
expression controls phagocytosis in Mertk+/− and Aath4aDBA/
DBA macrophages in a dose-dependent, not an all-or-none man-
ner. This is consistent with many published reports that disease-
related SNPs identified by GWAS (genome-wide association 
study) are usually located in introns or intergene regions rather 
than in coding sequences. Unlike diseases in which mutations in a 
single gene cause a drastic phenotype, the pathogenesis of athero-
sclerosis is more complex and involves numerous factors. SNPs 
or other alterations in regulatory regions typically lead to small 
changes in gene expression, which cumulatively influence suscep-
tibility to disease. Our experiments show that Mertk expression is 
likely reduced at the transcription level because the stability of 
Mertk mRNA was unchanged in the Aath4aDBA/DBA macrophages. 
Furthermore, our reporter assay tests show that the genetic differ-
ences that cause different Mertk expression in DBA/2J and 129S6 
are likely to be outside the proximal 1.1 kb promoter region, and 
search of eQTL database suggests that the expression of Mertk is 
affected by distant genetic variants. In humans, an SNP rs869016 
in intron 1 of MERTK is associated with decreased risk of carotid 
atherosclerosis, although it is unknown whether the SNP modu-
lates Mertk mRNA expression.20 Further investigation of the caus-
ative variants is clearly required.
Efferocytosis, the phagocytosis of apoptotic cells by 
macrophages, is critical in preventing progression of athero-
sclerosis.21 Consistently, it has been shown that Mertk−/−Apoe−/− 
mice fed a Western-type diet have increased numbers of apop-
totic cells and expanded necrosis in advanced lesions.12 In 
early plaques, removal of apoptotic cells is normally efficient; 
although, we have observed signs of basophilic (dystrophic) 
calcium deposits even in the early raised plaques of Aath4aDBA/
DBA mice. Our attempt to detect apoptotic cells in vivo in plaques 
by TUNEL assay was not productive to make a comparison 
because TUNEL-positive nuclei were few per section in both 
Aath4a129/129 and Aath4aDBA/DBA. This is because mice were fed 
with normal chow to eliminate additional effects caused by 
high-fat diet, and most of the lesions we observed were at their 
early stages. However, the calcium deposits are likely the rem-
nants of dead/dying cells via apoptotic and necrotic processes, 
giving strong evidence that the normal process of removing 
dead cells is restricted in the Aath4aDBA/DBA mice. Delayed 
apoptotic cell clearance is expected to cause acceleration of 
plaque development and necrotic core formation. The cal-
cium deposits in the early plaques, however, seem to be short-
lived because larger calcified areas in advanced Aath4aDBA/DBA 
plaques are not different from the control plaques and are seen 
mostly deeper in the intima near the internal elastic lamina. 
Although the thickness of fibrous caps was not significantly 
different, the Aath4aDBA/DBA plaques contained less interstitial 
matrix proteins than similar-sized plaques in the control mice. 
In advanced plaques, efferocytosis by macrophages becomes 
less effective than in early plaques, but an alteration in the 
balance between synthesis and degradation of matrix protein 
would be expected to contribute to vulnerable plaque mor-
phology. Although we have not encountered any premature 
deaths associated with the Aath4aDBA/DBA mice, a more detailed 
examination of later stage plaques would be worthwhile.
Despite the well-known heterogeneity of mouse perito-
neal macrophages,15,16 we found that MERTK is expressed in 
both LPMs and SPMs, and that it is similarly reduced in both 
populations of Aath4aDBA/DBA macrophages. We also observed 
that the LPMs, which have higher phagocytic activity than 
SPMs,17 were consistently fewer in Aath4aDBA/DBA than in con-
trols. Fewer LPMs and more SPMs could be another factor 
contributing to the reduced phagocytosis in Aath4aDBA/DBA 
peritoneal macrophages. SPMs are induced from circulat-
ing monocytes by inflammatory stimuli, whereas LPMs 
are thought to be tissue-resident macrophages, maintained 
locally by differentiation from precursor cells. Macrophages 
in atherosclerotic plaques are similarly heterogeneous,22,23 
and the role of circulating monocyte-derived macrophages 
in the development of plaques has been well-documented. 
Evidence is also beginning to accumulate that tissue-resident 
macrophages originating from the adventitial precursor cells 
contribute to atherogenesis. Factors that control the relative 
balance of these populations are not known, but a shift in the 
population of the Aath4aDBA/DBA macrophages in their plaques 
is conceivable. Whether MERTK expression directly affects 
this shift or not requires further study.
Although we identified Aath4 as a QTL specific to the arch 
lesion, the Aath4aDBA/DBA mice have significantly larger plaques 
in both the aortic arch and the root. This is in agreement with 
our prediction that the reduced efferocytosis of Aath4aDBA/DBA 
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root. Our previous studies of F2 population between 129S6- 
Apoe−/− and C57BL/6-Apoe−/− indicated that 129S6 genome 
carries the sequence that affects the aortic arch geometry, which 
are also associated with increased aortic arch atherosclerosis.2 
Therefore, the variant in Mertk expression is a risk factor that 
is additional to the 129S6 sequences that determine the aor-
tic arch development because the Aath4aDBA/DBA strain is based 
upon the129S6 genome. Moreover, the contribution of Mertk 
expression to the 50% increase in root lesion is, although sig-
nificant, relatively small, considering that the parental DBA/2J 
show 10× larger plaques in the root than 129S6 mice.
The genomic region of DBA/2J carried in the Aath4aDBA/DBA 
mice is large, and the effect of DNA variants in other loca-
tions in this region must be considered. For example, Siglec1 
at 131 Mb, which encodes sialoadhesin (CD169), is involved 
in the retention of hematopoietic stem cells in the bone mar-
row niche.24 It is also expressed in a subset of tissue-resi-
dent macrophages, preventing excessive inflammation upon 
injury.25 Similarly, CD169 may also play a role in phagocy-
tosis.26,27 Altered expression of Bcl2l11 at 128 Mb, encoding 
for a proapoptotic protein Bim, could affect early cell death 
in the Aath4aDBA/DBA plaques. In addition, as the backcrossed 
region in the Aath4aDBA/DBA line is the proximal half of Aath4, 
the distal half may include genes that are proatherogenic only 
in the arch, or are athero-suppressive specifically in the root. 
One of the candidates in distal Aath4 is Cd93 at 148 Mb, a 
transmembrane glycoprotein which is expressed in endothe-
lial and myeloid cells. CD93-deficient mice show a defect in 
the clearance of apoptotic cells in vivo,28 and an SNP in Cd93 
gene is associated with an increased risk of coronary heart 
disease.29 Analysis of a congenic line carrying the distal half 
of Aath4 of DBA/2J is currently under way.
We also note that the plaque size difference was observed 
only in Aath4aDBA/DBA males, whereas the male/female dif-
ferences in plaque size were not seen in the parental strains: 
DBA/2J-Apoe−/− mice show larger root lesions compared 
with 129S6-Apoe−/− in both males and females3; arch lesion 
size was comparable between the 2 strains in both males and 
females.4 The QTLs on Chr 2 were detected in both males 
and females in the F2 population from DBA/2J-Apoe−/− and 
129S6-Apoe−/− mice.3,4 Because no QTL was detected on Chr 
2 for plasma lipids in the intercross between the 2 strains, the 
plasma lipid differences between males and females are not 
likely the strong determinant of the plaque size differences.3 
The major determinants for the plaque sizes in females must, 
therefore, lie outside of the Aath4a interval. The sex dimor-
phism in the Aath4aDBA/DBA mice requires further investigation.
In summary, our experiments have shown that the DBA 
allele of the 5′ region of Aath4 causes inefficient efferocy-
tosis via lower expression of MERTK, and that difference 
contributes to the enhanced plaque development observed in 
Aath4aDBA/DBA mice. Because the effects of reduced MERTK 
and efferocytosis are seen in the both aortic arch and root 
areas, further studies will be required to fully understand the 
factors that cause location specificity in atherosclerosis.
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Highlights
• Aath4aDBA/DBA, a congenic line of an atherosclerosis QTL Aath4 on distal Chr 2, was generated by transferring DBA/2J alleles of Aath4 to 
the129S6-Apoe−/− strain.
• Aath4aDBA/DBA males develop larger plaques and peritoneal macrophages isolated from Aath4aDBA/DBA showed reduced phagocytosis of apoptotic 
cells.
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